Originalkatalog | Verfügbarkeit prüfen

Efficacy of switching to infliximab in patients with Crohn's disease with loss of response to adalimumab.

Peeters, H., Louis, Edouard, Baert, F., Dewit, O., Coche, J. C., Ferrante, M., Lambrecht, G., Colard, A., Van Gossum, A., Bossuyt, P., Moreels, T., Vander Cruyssen, B., Gils, A., De Vos, M.
2018